Pulmonary vascular remodeling

Doug Miniati1

  • 1Division of Pediatric Surgery, Department of Surgery, University of California, San Francisco School of Medicine, San Francisco, California, USA. miniatid@surgery.ucsf.edu

Insights

Congenital diaphragmatic hernia causes abnormal lung vasculature, leading to pulmonary hypertension in newborns. This review explores lung vascular development and therapies for this condition.

Area of Science:

  • Pulmonary vascular development
  • Neonatal circulation
  • Congenital diaphragmatic hernia

Background:

  • Abnormal pulmonary vasculature in congenital diaphragmatic hernia (CDH) critically affects patient outcomes.
  • Muscularized distal pulmonary arterioles impede neonatal adaptation to extrauterine circulation, causing severe pulmonary hypertension.
  • Understanding lung vascular development is crucial for managing CDH.

Purpose of the Study:

  • To review normal and abnormal lung vascular development in the context of CDH.
  • To identify current and potential therapeutic strategies for pulmonary vascular dysfunction in CDH.
  • To improve outcomes for neonates with congenital diaphragmatic hernia.

Main Methods:

  • Literature review of normal and abnormal pulmonary vascular development.
  • Analysis of the pathophysiology of pulmonary hypertension in CDH.
  • Synthesis of current and emerging therapeutic approaches.

Main Results:

  • CDH is associated with significant pulmonary vascular maladaptation.
  • Impaired vascular remodeling leads to persistent pulmonary hypertension.
  • Therapeutic targets focus on preserving or restoring vascular function.

Conclusions:

  • Pulmonary vascular dysfunction is a key determinant of outcome in CDH.
  • Targeting vascular development and function offers potential therapeutic benefits.
  • Further research is needed to optimize treatment strategies for CDH-related pulmonary hypertension.

Related Concept Videos

Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
Pulmonary Edema II: Pathophysiology01:18

Pulmonary Edema II: Pathophysiology

Pulmonary edema is the accumulation of fluid in the interstitial and alveolar spaces of the lungs, impairing gas exchange and oxygen delivery. It may be cardiogenic or noncardiogenic, but both reduce oxygenation and lung compliance.Cardiogenic Pulmonary EdemaCardiogenic edema results from increased hydrostatic pressure in pulmonary capillaries, usually due to left ventricular dysfunction from myocardial infarction, heart failure, or valvular disease. Ineffective cardiac pumping causes blood to...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...